The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Apoptosis: a mechanism of acute and chronic liver injury
Open accessAbstract
rompt removal of unwanted cells, such as senescent, damaged, genetically mutated, or virus infected cells, is crucial for the maintenance of liver health.This process is naturally achieved through a highly regulated programmed form of cell death called apoptosis.In healthy organisms, the number of cells eliminated by apoptosis equals the number of cells generated by mitosis, ensuring the proper organ homeostasis.In addition, ''physiological'' apoptosis allows the removal of cells with virtually no release of proinflammatory cytokines and minimal immune response.However, in pathophysiological situations, the balance between cell proliferation and cell death is often altered, with the consequent loss of tissue homeostasis and the onset of several liver diseases.Insufficient apoptosis, with failure of removal of cells carrying mutated genes, and unregulated proliferation within the context of a persistent inflammatory milieu, can promote the development of liver and biliary cancer.1-4 Paradoxically, a chronic apoptotic stimulus can also predispose to cancer development due to the high rate of regeneration invoked in the tissue, which elevates the risk of mitotic errors.In contrast, excessive and/or sustained apoptosis can lead to acute injuries, such as fulminant hepatitis and reperfusion damage, 5 6 or even chronic sustained injuries, such as alcoholic liver disease, cholestatic liver disease, and viral hepatitis.[7][8][9][10] Therefore, therapeutic strategies to inhibit apoptosis in liver injury, or selectively kill malignant cells in tumours, have the potential to provide a powerful tool for the treatment of liver disease.Indeed, with an improved understanding of the molecular pathways and the pathophysiological role of apoptosis, new drugs aimed at therapeutically modulating apoptosis are now available for clinical trials and/or as new therapeutic options for the treatment of several human diseases.In this review, we will focus on the role of apoptosis in selected liver diseases, such as alcoholic liver disease, viral hepatitis, cholestatic liver diseases, non-alcoholic liver disease, and hepatocellular carcinoma.11-14 We will also review some pro-and antiapoptotic therapies currently in use (or in clinical trial) or potentially useful for the treatment of human diseases, including liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Programmed Cell Death in Animal Development
Jacobson, M. D., Weil, M., & Raff, M. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81873-5 · Cited by 2,698
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Nicholson, D. W., & Thornberry, N. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01085-2 · Cited by 2,409
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,080
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
CD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
Cheng, E. H.-Y. A., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T., & Korsmeyer, S. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00320-3 · Cited by 1,707
Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H., & Golstein, P. (1994) · Science · doi:10.1126/science.7518614 · Cited by 1,516
The Bcl-2 family: roles in cell survival and oncogenesis
Cory, S., Huang, D. C. S., & Adams, J. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207102 · Cited by 1,463
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c
Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., Thompson, C. B., & Korsmeyer, S. J. (2000) · Genes & Development · doi:10.1101/gad.14.16.2060 · Cited by 1,268
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
RNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Self-citationCytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways
Lowin, B., Hahne, M., Mattmann, C., & Tschopp, J. (1994) · Nature · doi:10.1038/370650a0 · Cited by 1,051
Inhibition of Bax Channel-Forming Activity by Bcl-2
Antonsson, B., Conti, F., Ciavatta, A., Montessuit, S., Lewis, S., Martinou, I., Bernasconi, L., Bernard, A., Mermod, J.-J., Mazzei, G., et al. (1997) · Science · doi:10.1126/science.277.5324.370 · Cited by 1,028
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
Yin, X.-M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K. A., & Korsmeyer, S. J. (1999) · Nature · doi:10.1038/23730 · Cited by 1,004
Lauber, K., Bohn, E., Kröber, S. M., Xiao, Y.-J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00422-7 · Cited by 967
BID: a novel BH3 domain-only death agonist.
Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L., & Korsmeyer, S. J. (1996) · Genes & Development · doi:10.1101/gad.10.22.2859 · Cited by 946
Martinon, F., & Tschopp, J. (2004) · Cell · doi:10.1016/j.cell.2004.05.004 · Cited by 938
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Feldstein, A. E., Werneburg, N. W., Canbay, A., Guicciardi, M. E., Bronk, S. F., Rydzewski, R., Burgart, L. J., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20283 · Cited by 834
Self-citationMüller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119174 · Cited by 748
Guicciardi, M. E., Deussing, J., Miyoshi, H., Bronk, S. F., Svingen, P. A., Peters, C., Kaufmann, S. H., & Gores, G. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9914 · Cited by 710
Self-citationInvolvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.
Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., & Runkel, L. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1223 · Cited by 692
Antonsson, B., Montessuit, S., Sanchez, B., & Martinou, J.-C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010810200 · Cited by 676
Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., & Schulte-Hermann, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5408 · Cited by 668
Leithäuser, F., Dhein, J., Mechtersheimer, G., Koretz, K., Brüderlein, S., Henne, C., Schmidt, A., Debatin, K., Krammer, P. H., & Möller, P. (1993) · PubMed · Cited by 625
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
Faubion, W. A., Guicciardi, M. E., Miyoshi, H., Bronk, S. F., Roberts, P. J., Svingen, P. A., Kaufmann, S. H., & Gores, G. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4765 · Cited by 536
Self-citationApoptosis: The nexus of liver injury and fibrosis
Canbay, A., Friedman, S., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20051 · Cited by 527
Self-citationHsu, Y.-T., & Youle, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10777 · Cited by 504
Bax and Bak Coalesce into Novel Mitochondria-Associated Clusters during Apoptosis
Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S.-H., & Youle, R. J. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.6.1265 · Cited by 477
Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression
Canbay, A., Feldstein, A. E., Higuchi, H., Werneburg, N., Grambihler, A., Bronk, S. F., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50472 · Cited by 470
Self-citationApoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic
Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., & Gores, G. J. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000069036.63405.5c · Cited by 417
Self-citationRibeiro, P. S., Cortez-Pinto, H., Solá, S., Castro, R. E., Ramalho, R. M., Baptista, A., Moura, M. C., Camilo, M. E., & Rodrigues, C. M. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40009.x · Cited by 395
Caspase 8 small interfering RNA prevents acute liver failure in mice
Zender, L., Hütker, S., Liedtke, C., Tillmann, H. L., Zender, S., Mundt, B., Waltemathe, M., Gösling, T., Flemming, P., Malek, N. P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1330920100 · Cited by 384
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C
Hiramatsu, N., Hayashi, N., Katayama, K., Mochizuki, K., Kawanishi, Y., Kasahara, A., Fusamoto, H., & Kamada, T. (1994) · Hepatology · doi:10.1002/hep.1840190606 · Cited by 357
Kohli, V., Selzner, M., Madden, J. F., Bentley, R. C., & Clavien, P.-A. (1999) · Transplantation · doi:10.1097/00007890-199904270-00003 · Cited by 333
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
Feldstein, A. E., Canbay, A., Guicciardi, M. E., Higuchi, H., Bronk, S. F., & Gores, G. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00460-4 · Cited by 320
Self-citationHepatocyte apoptosis after bile duct ligation in the mouse involves Fas
Miyoshi, H., Rust, C., Roberts, P. J., Burgart, L. J., & Gores, G. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70461-0 · Cited by 311
Self-citationFas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis
Canbay, A., Higuchi, H., Bronk, S. F., Taniai, M., Sebo, T. J., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35953 · Cited by 305
Self-citationCytokines and Alcoholic Liver Disease
McClain, C., Hill, D., Schmidt, J., & Diehl, A. (1993) · Seminars in Liver Disease · doi:10.1055/s-2007-1007347 · Cited by 279
Strand, S., Hofmann, W. J., Grambihler, A., Hug, H., Volkmann, M., Otto, G., Wesch, H., Mariani, S. M., Hack, V., Stremmel, W., et al. (1998) · Nature Medicine · doi:10.1038/nm0598-588 · Cited by 278
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
Natori, S., Rust, C., Stadheim, L. M., Srinivasan, A., Burgart, L. J., & Gores, G. J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00089-1 · Cited by 273
Self-citationApoptosis and hepatobiliary disease
Patel, T., & Gores, G. J. (1995) · Hepatology · doi:10.1002/hep.1840210635 · Cited by 264
Self-citationp53 gene mutation spectrum in hepatocellular carcinoma.
Oda, T., Tsuda, H., Scarpa, A., Sakamoto, M., & Hirohashi, S. (1992) · PubMed · Cited by 250
Expression and Role of Bcl–Xl in Human Hepatocellular Carcinomas
Takehara, T., Liu, X., Fujimoto, J., Friedman, S. L., & Takahashi, H. (2001) · Hepatology · doi:10.1053/jhep.2001.25387 · Cited by 246
Sensitization to Fas-Mediated Apoptosis by Hepatitis C Virus Core Protein
Ruggieri, A., Harada, T., Matsuura, Y., & Miyamura, T. (1997) · Virology · doi:10.1006/viro.1996.8420 · Cited by 244
Bantel, H., Lügering, A., Heidemann, J., Volkmann, X., Poremba, C., Strassburg, C. P., Manns, M. P., & Schulze-Osthoff, K. (2004) · Hepatology · doi:10.1002/hep.20411 · Cited by 242
Taimr, P., Higuchi, H., Kocova, E., Rippe, R. A., Friedman, S., & Gores, G. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50002 · Cited by 227
Self-citationTakehara, T., Tatsumi, T., Suzuki, T., Rucker, E. B., Hennighausen, L., Jinushi, M., Miyagi, T., Kanazawa, Y., & Hayashi, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.019 · Cited by 225
Chan, H., Bartos, D. P., & Owen-Schaub, L. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2098 · Cited by 225
Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas
Sodeman, T., Bronk, S. F., Roberts, P. J., Miyoshi, H., & Gores, G. J. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g992 · Cited by 216
Self-citationThe Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse
Canbay, A., Feldstein, A., Baskin-Bey, E., Bronk, S. F., & Gores, G. J. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060129 · Cited by 215
Self-citationOxidative Stress–Mediated Apoptosis of Hepatocytes Exposed to Acute Ethanol Intoxication
Kurose, I., Higuchi, H., Miura, S., Saito, H., Watanabe, N., Hokari, R., Hirokawa, M., Takaishi, M., Zeki, S., Nakamura, T., et al. (1997) · Hepatology · doi:10.1002/hep.510250219 · Cited by 214
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
Canbay, A., Guicciardi, M. E., Higuchi, H., Feldstein, A., Bronk, S. F., Rydzewski, R., Taniai, M., & Gores, G. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17740 · Cited by 193
Self-citationDeath Receptors in Liver Biology and Pathobiology
Faubion, W. A., & Gores, G. J. (1999) · Hepatology · doi:10.1002/hep.510290101 · Cited by 189
Self-citationDeath receptor-mediated apoptosis and the liver
Yoon, J.-H., & Gores, G. J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00209-x · Cited by 188
Self-citationThe Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis
Higuchi, H., Bronk, S. F., Takikawa, Y., Werneburg, N., Takimoto, R., El-Deiry, W., & Gores, G. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105300200 · Cited by 186
Self-citationp53 Upregulates Death Receptor 4 Expression through an Intronic p53 Binding Site
Liu, X., Yue, P., Khuri, F. R., & Sun, S.-Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1195 · Cited by 184
Dysregulation of Apoptosis as a Mechanism of Liver Disease: An Overview
Patel, T., Roberts, L., Jones, B., & Gores, G. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007147 · Cited by 184
Self-citationRust, C., & Gores, G. J. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00370-3 · Cited by 178
Self-citationHug, H., Strand, S., Grambihler, A., Galle, J., Hack, V., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28191 · Cited by 178
Role of Fas Ligand in Apoptosis Induced by Hepatitis C Virus Infection
Mita, E., Hayashi, N., Iio, S., Takehara, T., Hijioka, T., Kasahara, A., Fusamoto, H., & Kamada, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2483 · Cited by 173
Nutritional and Metabolic Considerations in the Etiology of Nonalcoholic Steatohepatitis
Nehra, V., Angulo, P., Buchman, A. L., & Lindor, K. D. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1012338828418 · Cited by 171
Bantel, H., Lügering, A., Poremba, C., Lügering, N., Held, J., Domschke, W., & Schulze-Osthoff, K. (2001) · Hepatology · doi:10.1053/jhep.2001.28229 · Cited by 166
Diao, J., Khine, A. A., Sarangi, F., Hsu, E., Iorio, C., Tibbles, L. A., Woodgett, J. R., Penninger, J., & Richardson, C. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006026200 · Cited by 165
COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells
Nzeako, U. C., Guicciardi, M. E., Yoon, J.-H., Bronk, S. F., & Gores, G. J. (2002) · Hepatology · doi:10.1053/jhep.2002.31774 · Cited by 163
Self-citationNeutrophil-mediated tissue injury in alcoholic hepatitis
Jaeschke, H. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00200-8 · Cited by 150
Apoptosis in hepatitis C virus infection
Bantel, H., & Schulze‐Osthoff, K. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401119 · Cited by 149
Makower, D., Rozenblit, A. M., Kaufman, H. L., Edelman, M. C., Lane, M. E., Zwiebel, J. A., Haynes, H., & Wadler, S. (2003) · PubMed · Cited by 148
Fas antigen expression in liver tissues of patients with chronic hepatitis B
Mochizuki, K., Hayashi, N., Hiramatsu, N., Katayama, K., Kawanishi, Y., Kasahara, A., Fusamoto, H., & Kamada, T. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80178-4 · Cited by 145
French, S. W., Wong, K., Jui, L., Albano, E., Hagbjörk, A.-L., & Ingelman‐Sundberg, M. (1993) · Experimental and Molecular Pathology · doi:10.1006/exmp.1993.1006 · Cited by 143
Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis
Ziol, M., Tepper, M., Lohez, M., Arcangeli, G., Ganne‐Carrié, N., Christidis, C., Trinchet, J., Beaugrand, M., Guillet, J., & Guettier, C. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00047-7 · Cited by 133
Okano, H., Shiraki, K., Inoue, H., Kawakita, T., Yamanaka, T., Deguchi, M., Sugimoto, K., Sakai, T., Ohmori, S., Fujikawa, K., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000079328.76631.28 · Cited by 132
Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease
Guicciardi, M. E., & Gores, G. J. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80033-0 · Cited by 118
Self-citationMachida, K., Tsukiyama–Kohara, K., Seike, E., Toné, S., Shibasaki, F., Shimizu, M., Takahashi, H., Hayashi, Y. K., Funata, N., Taya, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010137200 · Cited by 114
Clinical Implications of the p53 Tumor-Suppressor Gene
Müller, M., Volkmann, M., Zentgraf, H., & Galle, P. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403243301215 · Cited by 110
Pathology and Pathogenesis of Hepatocellular Carcinoma
Röcken, C., & Carl‐McGrath, S. (2001) · Digestive Diseases · doi:10.1159/000050693 · Cited by 109
長尾, 美., Nakajima, Y., Hisanaga, M., Kayagaki, N., Kanehiro, H., Aomatsu, Y., Ko, S., Yagita∥, H., Yamada, T., Okumura, K., et al. (1999) · Hepatology · doi:10.1002/hep.510300237 · Cited by 108
Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure
Ryo, K., Kamogawa, Y., Ikeda, I., Yamauchi, K., Yonehara, S., Nagata, S., & Hayashi, N. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01060-1 · Cited by 102
Pan, J., Duan, L., Sun, B. S., & Feitelson, M. A. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-1-171 · Cited by 102
Valentino, K. L., Gutierrez, M. E., Sanchez, R., Winship, M. J., & Shapiro, D. A. (2003) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp41441 · Cited by 101
Goldin, R. D., Hunt, N. C. A., Clark, J., & Wickramasinghe, S. N. (1993) · The Journal of Pathology · doi:10.1002/path.1711710115 · Cited by 100
Pianko, S., Patella, S., Ostapowicz, G., Desmond, P. V., & Sievert, W. (2001) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2001.00316.x · Cited by 94
Baskin-Bey, E. S., Canbay, A. E., Bronk, S. F., Werneburg, N. W., Guicciardi, M. E., Nyberg, S. L., & Gores, G. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00316.2004 · Cited by 94
Self-citationFiorucci, S., Mencarelli, A., Palazzetti, B., Soldato, P. D., Morelli, A., & Ignarro, L. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041603898 · Cited by 91
Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis
Fox, C. K., Furtwaengler, A., Nepomuceno, R. R., Martinez, O. M., & Krams, S. M. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.021004272.x · Cited by 91
Subcellular changes and apoptosis induced by ethanol in rat liver
Benedetti, A., Brunelli, E., Risicato, R., Cilluffo, T., Jézéquel, A. M., & Orlandi, F. (1988) · Journal of Hepatology · doi:10.1016/s0168-8278(88)80024-2 · Cited by 90
Higuchi, H., Bronk, S. F., Taniai, M., Canbay, A. E., & Gores, G. J. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040030 · Cited by 89
Self-citationHigaki, K., Yano, H., & Kojiro, M. (1996) · Europe PMC (PubMed Central) · Cited by 89
Anderson, S. C., Johnson, D. E., Harris, M. P., et al. (1998) · PubMed · Cited by 88
Terradillos, O., Coste, A. D. L., Pollicino, T., Neuveut, C., Sitterlin, D., Lecoeur, H., Gougeon, M., Kahn, A., & Buendia, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205110 · Cited by 85
Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease
Taïeb, J., Mathurin, P., Poynard, T., Gougerot-Pocidalo, M. A., & Chollet‐Martin, S. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78614-1 · Cited by 82
Inflammation in response to hepatocellular apoptosis
Jaeschke, H. (2002) · Hepatology · doi:10.1053/jhep.2002.0350964 · Cited by 78
Apoptosis and hepatobiliary disease*1
PATEL, T. (1995) · Hepatology · doi:10.1016/0270-9139(95)90481-6 · Cited by 77
Tang, T., Kwekkeboom, J., Laman, J. D., Niesters, H. G. M., Zondervan, P. E., de Man, R. A., Schalm, S. W., & Janssen, H. L. A. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00412.x · Cited by 70
Cholangiocarcinomas express fas ligand and disable the fas receptor
Que, F. G., Phan, V., Phan, V. H., et al. (1999) · Hepatology · doi:10.1002/hep.510300618 · Cited by 68
Virally Infected Hepatocytes Are Resistant to Perforin-Dependent CTL Effector Mechanisms
Kafrouni, M. I., Brown, G., & Thiele, D. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1566 · Cited by 68
Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus
Rivero, M., Crespo, J., Fábrega, E., Casafont, F., Mayorga, M., Gómez‐Fleitas, M., & Pons‐Romero, F. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00338.x · Cited by 64
Bid Antisense Attenuates Bile Acid-Induced Apoptosis and Cholestatic Liver Injury
Higuchi, H., Miyoshi, H., Bronk, S. F., Zhang, H., Dean, N. S., & Gores, G. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29204-1 · Cited by 63
Self-citationLuo, K. X., Zhu, Y. ‐., Zhang, L. ‐., He, H., Wang, X. ‐., & Zhang, L. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00053.x · Cited by 52
Costelli, P., Aoki, M. P., Zingaro, B., Carbó, N., Reffo, P., López-Soriano, F. J., Bonelli, G., Argilés, J. M. A., & Baccino, F. M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401281 · Cited by 48
Ehrmann, J., Galuszková, D., Ehrmann, J., Krè, I., Jezdínská, V., Ek, B. V., Murray, P. G., & Koláø, Z. (2000) · Pathology & Oncology Research · doi:10.1007/bf03032363 · Cited by 44
Differential modulation of cellular death and survival pathways by conjugated bile acids
Torchia, E. C., Stolz, A., & Agellon, L. B. (2001) · BMC Biochemistry · doi:10.1186/1471-2091-2-11 · Cited by 42
Fas antigen expression in hepatocellular carcinoma tissues.
Ito, Y., Takeda, T., Umeshita, K., Sakon, M., Wakasa, K., Matsuura∥, N., & Monden, M. (1998) · Oncology Reports · doi:10.3892/or.5.1.41 · Cited by 42
Deaciuc, I. V., D'Souza, N. B., & Spitzer, J. J. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01511.x · Cited by 39
Reversible Kupffer cell suppression in biliary obstruction is caused by hydrophobic bile acids
Sung, J. J. �., & Go, M. Y. Y. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80099-3 · Cited by 35
Fas-mediated apoptosis in acute alcoholic hepatitis.
Tagami, A., Ohnishi, H., Moriwaki, H., Phillips, M. G., & Hughes, R. D. (2003) · PubMed · Cited by 27
Tissue-specific regulation of Fas/APO-1/CD95 expression by p53
Lin, P. J. C., Bush, J., Cheung, K. J., & Li, G. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.2.261 · Cited by 23
Gene Therapy of Hepatocellular Carcinoma
Ruiz, J., Mazzolini, G. D., Sangro, B., Qian, C., & Prìeto, J. (2001) · Digestive Diseases · doi:10.1159/000050699 · Cited by 22
Yoneyama, K. (2002) · Hepatology Research · doi:10.1016/s1386-6346(02)00137-7 · Cited by 21
Fiore, G., Piazzolla, G., Galetta, V., Caccetta, L., Schiraldi, O., & Antonaci, S. (1999) · PubMed · Cited by 17
Cited by
Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J., et al. (2020) · doi:10.1101/2020.02.03.931766 · Cited by 952
“The liver damage can be caused by multitudinous factors such as exposure to toxins, excessive alcohol consumption, bile duct prevention obstruction, and viral infections [5].”
BackgroundBile-acid-induced cell injury and protection
Perez, M. J., & Briz, O. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1677 · Cited by 717
Feldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712
Redox mechanisms in hepatic chronic wound healing and fibrogenesis
Novo, E., & Parola, M. (2008) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-1-5 · Cited by 406
An integrated perfusion machine preserves injured human livers for 1 week
Eshmuminov, D., Becker, D., Bautista Borrego, L., Hefti, M., Schuler, M. J., Hagedorn, C., Muller, X., Mueller, M., Onder, C., Graf, R., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0374-x · Cited by 389
Metadata
- Authors
- Guicciardi, M. E., & Gores, G. J.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2005-06-10
- Volume
- 54
- Issue
- 7
- Pages
- 1024-1033
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2097500515
- Cited by
- 514
- References
- 127
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.